U.S., Dec. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07308184) titled 'Bridge Study to Evaluate the Efficacy and Safety of IN-B00009 Injection in Patients With T2DM Inadequately Controlled by Diet and Exercise Alone' on Dec. 15.
Brief Summary: This Phase 3 Bridge study is designed to evaluate the efficacy and safety of IN-B00009 Injection in Patients with T2DM Inadequately Controlled by Diet and Exercise Alone
Study Start Date: Dec., 2025
Study Type: INTERVENTIONAL
Condition:
Diabetes (DM)
Diabetes Mellitus Type 2
Intervention:
DRUG: IN-B00009
Test drug
DRUG: Placebo
Placebo drug
Recruitment Status: NOT_YET_RECRUITING
Sponsor: HK inno.N Corporation
Published by HT Digital Content Services w...